Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Karel Cwiertka"'
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for medically inoperable early-stage non-small cell lung cancer (ES-NSCLC), but which patients benefit from stereotactic radiotherapy is unclear. The aim of this
Externí odkaz:
https://doaj.org/article/7a87c4fefef646f3af951c286e79ea03
Autor:
Dagmar Horakova, Katerina Bouchalova, Karel Cwiertka, Ladislav Stepanek, Jana Vlckova, Helena Kollarova
Publikováno v:
Biomedical Papers, Vol 162, Iss 2, Pp 83-89 (2018)
Triple negative breast cancer (TNBC) is an aggressive form of breast cancer (BC) with a poor prognosis. Second, patients cannot benefit from targeted therapy, except for those with BRCA1/2 mutations, for whom poly (ADP-ribose) polymerase (PARP) inhib
Externí odkaz:
https://doaj.org/article/0b244305da0d433a8c0cb4f5f6e3f998
Autor:
Marcel Matzenauer, David Vrana, Zuzana Vlachova, Karel Cwiertka, Ondrej Kalita, Bohuslav Melichar
Publikováno v:
Biomedical Papers, Vol 160, Iss 3, Pp 412-416 (2016)
Background and Aims: As treatments for primary cancers continue to improve life expectancy, unfortunately, brain metastases also appear to be constantly increasing and life expectancy for patients with brain metastases is low. Longer survival and imp
Externí odkaz:
https://doaj.org/article/bc89734f980241d7a49a2326d25994fe
Autor:
Martin Stašek, Radomyr Zhydkov, René Aujeský, Čestmír Neoral, Radek Vrba, Petra Ochmanová, Karel Cwiertka, Dušan Klos
Publikováno v:
European Journal of Surgical Oncology. 49:e188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::553eb79f3457c0a7896e2c5613ffc66a
https://doi.org/10.1016/j.ejso.2022.11.521
https://doi.org/10.1016/j.ejso.2022.11.521
Autor:
Zdenek Hodny, Jirina Bartkova, Mariam Gachechiladze, Dana Simkova, Martin Mistrik, Dusana Majera, Jan Bouchal, Jana Steigerova, Karel Cwiertka, Jan Gursky, Gabriela Korinkova, Zdenek Skrott, Daniela Kurfürstová, Jiri Bartek
Publikováno v:
The Prostate. 79:352-362
Background Castration-resistant prostate cancer (PCa) represents a serious health challenge. Based on mechanistically-supported rationale we explored new therapeutic options based on clinically available drugs with anticancer effects, including inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff31228b5160f48d157463a8f1ae171
https://doi.org/10.1002/pros.23741
https://doi.org/10.1002/pros.23741
Autor:
Jiří Petera, David Vrána, Martina Vasakova, Aleš Kudláček, Jana Skřičková, Martina Sterclova, Miloš Pešek, Karel Cwiertka, Vítězslav Kolek
Publikováno v:
Klinicka Onkologie. 30:303-306
Background This article is a joint statement of the Czech Pneumological and Physiological Society and the Czech Society for Radiation Oncology, Biology and Physics, and reviews current opinions on radiotherapy in patients with idiopathic pulmonary fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec9865940cabd35d4dfd808e8d45514
https://doi.org/10.14735/amko2017303
https://doi.org/10.14735/amko2017303
Autor:
David Vrána, Marcel Matzenauer, David Gremlica, Zuzana Vlachová, Karel Cwiertka, Hana Študentová, O. Kalita
Publikováno v:
Oncology Letters. 11:3777-3781
Renal cell cancer patients with brain metastatic disease generally have poor prognosis. Treatment options include surgery, radiotherapy, targeted therapy or best supportive care with respect to disease burden, patient preference and performance statu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c7e252ec3061f30e912e0bbe904f590
https://doi.org/10.3892/ol.2016.4440
https://doi.org/10.3892/ol.2016.4440
Autor:
Jana Vlčková, Karel Cwiertka, Katerina Bouchalova, Ladislav Stepanek, Dagmar Horáková, Helena Kollárová
Publikováno v:
Biomedical Papers, Vol 162, Iss 2, Pp 83-89 (2018)
Triple negative breast cancer (TNBC) is an aggressive form of breast cancer (BC) with a poor prognosis. Second, patients cannot benefit from targeted therapy, except for those with BRCA1/2 mutations, for whom poly (ADP-ribose) polymerase (PARP) inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fc647d8d6ed824292c0b5457f36e0d
https://pubmed.ncbi.nlm.nih.gov/29765171
https://pubmed.ncbi.nlm.nih.gov/29765171
Publikováno v:
Klinicka onkologie. 26:143-146
BACKGROUND Chest movements during the breathing cycle represent a significant problem during radiotherapy of target volumes in the chest. There are several methods how to solve this problem. CASE We have used Active breathing control-moderate inspira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e522dd2dfeed9b55e4b65f9c56e1df
https://doi.org/10.14735/amko2013143
https://doi.org/10.14735/amko2013143
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 29(5)
Background Malignant peripheral nerve sheath tumor schwannoma (MPNST), also known as malignant schwannoma, is a very rare tumor accounting for only 2% of all sarcomas. The prognosis is relatively poor, with a 5-year survival rate of 46-69%. The treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030dbf04778e7f2b043e2386567eb880
https://pubmed.ncbi.nlm.nih.gov/27739316
https://pubmed.ncbi.nlm.nih.gov/27739316